$
Sep 6, 2026$MRNA Stock Decline Continues After Rothschild Sell Rating
Moderna Inc. ($MRNA) stock declined for a second consecutive day on September 6, 2026. Rothschild...
Sep 6, 20261 min read0 reactions0 comments
Back to articles 
Jun 25, 2026
Tag archive
#mrna
M
Aug 26, 2026MRNA: Moderna Looks Overvalued Amid Drug Pricing Speculation
Moderna (MRNA) faces valuation concerns, with the GF Value™ metric suggesting a 508.2%...
Aug 26, 20261 min read0 reactions0 comments
M
Aug 23, 2026MRNA: Moderna's Melanoma Therapy Candidate Sparks 179% Stock Surge
Moderna's (MRNA) melanoma therapy candidate, mRNA-4157/V940, showed a 64% reduction in distant...
Aug 23, 20261 min read0 reactions0 comments
M
Aug 22, 2026MRNA Moderna Soars on Cancer Vaccine Breakthrough News
Moderna (MRNA) stock experienced a significant price surge, reportedly up to 170%, due to a major...
Aug 22, 20261 min read0 reactions0 comments
$
Aug 20, 2026$MRNA: Moderna Shares Surge on Positive Trial Data Amidst Increased Buzz
Moderna ($MRNA) shares gained traction due to positive clinical trial results. The company...
Aug 20, 20261 min read0 reactions0 comments
M
Aug 20, 2026MRNA Moderna Stock Rockets on Positive mRNA Cancer Vaccine Data
Moderna (MRNA) stock surged 177% following positive Phase 3 results for its mRNA cancer vaccine. The...
Aug 20, 20261 min read0 reactions0 comments
M
Aug 20, 2026MRNA: Moderna's Melanoma Vaccine Shows Promise, Boosting Turnaround
Moderna's personalized mRNA melanoma vaccine, Intrismeran, met its primary goal in a Phase 2b...
Aug 20, 20261 min read0 reactions0 comments
Moderna's mRNA Approval and It…
Originally published at norvik.tech Introduction Deep dive into the FDA's approval of...
Jun 25, 20263 min read0 reactions0 comments